Metal oxide encapsulated drug compositions and methods of preparing the same
A method of preparing a pharmaceutical composition having a drug-containing core enclosed by one or more metal oxide materials is provided. The method includes the sequential steps of (a) loading the particles comprising the drug into a reactor, (b) applying a vaporous or gaseous metal precursor to the particles in the reactor, (c) performing one or more pump-purge cycles of the reactor using inert gas, (d) applying a vaporous or gaseous oxidant to the particles in the reactor, and (e) performing one or more pump-purge cycles of the reactor using inert gas. The temperature of the particles does not exceed 35° C. This produces a pharmaceutical composition comprising a drug containing core enclosed by one or more metal oxide materials.
1. A method of preparing a pharmaceutical composition comprising a drug- containing core enclosed by one or more metal oxide materials, the method comprising the sequential steps of:
(a) loading particles comprising the drug into a reactor, wherein the particles have a median particle size, on a volume average basis between 0.1 μm and 1000 μm;
(b) applying a vaporous or gaseous metal precursor to the particles in the reactor;
(c) performing one or more pump-purge cycles of the reactor using an inert gas;
(d) applying vaporous or gaseous water as an oxidant to the particles in the reactor;
(e) performing one or more pump-purge cycles of the reactor using the inert gas; and
(f) repeating steps (b)-(e) one or more times to increase the total thickness of the one or more metal oxide materials that enclose the core, wherein the particles remain in the reactor during the repeated steps, each pump-purge cycle comprises flowing the inert gas into the reactor chamber to a desired pressure and after a delay time pumping the inert gas out of the reactor until the pressure of the inert gas is below 1 torr and repeating the steps of flowing the inert gas into the reactor chamber to a desired pressure and after a delay time pumping the inert gas out of the reactor until the pressure of the inert gas is below 1 torr, the temperature of the particles does not exceed 35° C., thereby producing a pharmaceutical composition comprising a drug containing core enclosed by one or more metal oxide materials,
wherein the one or more metal oxide materials are selected from the group consisting of: aluminum oxide, titanium oxide, iron oxide, gallium oxide, magnesium oxide, zinc oxide, niobium oxide, hafnium oxide, tantalum oxide, lanthanum oxide, and zirconium dioxide.
2. The method of claim 1 , wherein the reactor pressure is allowed to stabilize following step (a), step (b), and/or step (d).
3. The method of claim 1 , wherein a subset of vapor or gaseous content is pumped out prior to step (c) and/or step (e).
4. The method of claim 1 , wherein the particles comprise a drug and one or more pharmaceutically acceptable excipients.
5. The method of claim 1 , wherein the particles have a median particle size, on a volume average basis between 0.1 μm and 1000 μm.
6. The method of claim 1 , wherein the pharmaceutical composition is removed from the reactor and admixed with a pharmaceutically acceptable diluent or carrier.
7. The method of claim 1 , wherein the particles consist essentially of the drug.
8. The method of claim 1 , wherein the drug is a small molecule, virus particle, polypeptide, polynucleotide, a composition comprising polypeptide and lipid, or a composition comprising polynucleotide and lipid.
9. The method of claim 1 , wherein the one or more metal oxide materials are selected from the group consisting of: aluminum oxide and titanium oxide.
10. The method of claim 1 , wherein the reactor contents are agitated prior to and/or during step (b), step (c), and/or step (e).
11. The method of claim 1 , wherein the temperature of the particles remains between 22° C. and 35° C.
12. The method of claim 1 , wherein the inert gas is nitrogen gas or a noble gas.
13. The method of claim 12 , wherein the inert gas is nitrogen gas.
14. The method of claim 1 , wherein the drug is a small molecule drug that is selected from the group consisting of: acetaminophen, clarithromycin, azithromycin, ibuprofen, fluticasone propionate, salmeterol, pazopanib HC 1 , palbociclib, and amoxicillin potassium clavulanate.
15. The method of claim 1 , wherein the drug is a small molecule drug that is selected from the group consisting of: clarithromycin, clarithromycin carbomer complex, pazopanib HC 1 , palbociclib, and amoxicillin potassium clavulanate.
16. The method of claim 1 , wherein step (c) is repeated between 6 and 20 additional times.
17. The method of claim 1 , wherein step (e) is repeated between 1 and 10 additional times.
18. The method of claim 1 , wherein the one or more metal oxide materials are selected from the group consisting of aluminum oxide, titanium oxide, and zinc oxide.